SCHEMBL25531054

SCHEMBL25531054

CC1CCC(N(Cc2ccc(C(C)(C)C)cc2)CC2CC2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 4/20 0.42
▸ HDAC3 O15379 1/20 0.41
▸ HDAC8 Q9BY41 1/20 0.41
▸ HDAC6 Q9UBN7 1/20 0.41
▸ LTA4H P09960 1/20 0.39
▸ SLC6A2 P23975 6/20 0.39
▸ SLC6A4 P31645 6/20 0.39
▸ CYP2D6 P10635 2/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ SLC6A3 Q01959 1/20 0.36
▸ EP300 Q09472 2/20 0.35
▸ ADRA2A P08913 2/20 0.33
▸ NR1I2 O75469 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ ACHE P22303 1/20 0.33
▸ HTR2A P28223 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ ADRA2B P18089 1/20 0.33
▸ ADRA2C P18825 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12891100 0.75 EP300 (0.47) SIGMAR1HDAC3HDAC8HDAC6SLC6A2
SCHEMBL12448946 0.72 — —
SCHEMBL12891077 0.72 HRH3 (0.56) SIGMAR1HDAC3HDAC8HDAC6LTA4H
SCHEMBL21789675 0.70 SLC6A2 (0.51) SLC6A2SLC6A4SLC6A3ACHE
SCHEMBL20064499 0.70 SLC6A2 (0.51) SLC6A2SLC6A4SLC6A3ACHE
SCHEMBL5993776 0.68 SLC6A2 (0.68) SLC6A2SLC6A4CYP2D6SLC6A3
SCHEMBL22255225 0.68 LTA4H (0.38) LTA4HSLC6A2SLC6A4SLC6A3
SCHEMBL6912630 0.66 HDAC3 (0.47) HDAC3HDAC8HDAC6SLC6A2SLC6A4
SCHEMBL6910541 0.66 HDAC3 (0.42) HDAC3HDAC8HDAC6SLC6A2SLC6A4
SCHEMBL18828701 0.66 LTA4H (0.59) LTA4HSLC6A2SLC6A4CYP2D6SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230159491-A1 Antimicrobial Compounds and Methods NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2023-05-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230159491-A1 Antimicrobial Compounds and Methods MPO, NISCH, RPN2 SIGMAR1 1380/4885HDAC3 1149/4885HDAC8 1798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback